GHG
GreenTree Hospitality Group Ltd.
$1.13
0.00%
$114.0M
No data for this timeframe.
Vol
Market Cap$114.0M
Cap SizeMicro Cap
Inst. Holders1 funds
Inst. Value$320.9K
Inst. Activity0 buys / 1 sells
Recent Activity
Inst.
UBS Group AG — NEAR_EXIT
78 shares ($172.00)
Inst.
UBS Group AG — NEW
18,950 shares ($38.7K)
Analyst Ratings
0Strong Buy
0Buy
3Hold
4Sell
1Strong Sell
Historical Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Dec 29, 2022 | Citigroup | MAINTAIN | Buy |
| Mar 29, 2022 | B of A Securities | MAINTAIN | Buy |
| Jan 24, 2022 | Morgan Stanley | DOWNGRADE | Overweight → Equal-Weight |
| Aug 17, 2020 | B of A Securities | MAINTAIN | Buy |
| Feb 5, 2020 | CLSA | DOWNGRADE | Buy → Outperform |
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $320.9K | — |
1 institutional holders with $320.9K total value (189,889 shares) as of 2025-Q4. Top holders: RENAISSANCE.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | 189,889 | $320.9K | 100.0% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 18,950 | 78 | -99.6% | $172.00 | 2025-Q3 |
| UBS Group AG | NEW | — | 18,950 | — | $38.7K | 2025-Q2 |
| CITADEL ADVISORS LLC | NEW | — | 12,703 | — | $30.7K | 2025-Q1 |
| MORGAN STANLEY | TRIM | 150 | 110 | -26.7% | $340.00 | 2024-Q3 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
No SEC filing reports analyzed yet. Reports are generated when new filings are detected and processed by the LLM pipeline.
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution (last covering-analyst action Dec 2022): 0% buy across 8 analysts — 0 strong buy, 0 buy, 3 hold, 4 sell, 1 strong sell. No current recommendation available.
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
6 analyst firms have rated this stock: 1 upgrades, 2 downgrades, 4 initiations.
Historical Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| Dec 29, 2022 | Citigroup | MAINTAIN | — | Buy |
| Mar 29, 2022 | B of A Securities | MAINTAIN | — | Buy |
| Jan 24, 2022 | Morgan Stanley | DOWNGRADE | Overweight | Equal-Weight |
| Aug 17, 2020 | B of A Securities | MAINTAIN | — | Buy |
| Feb 5, 2020 | CLSA | DOWNGRADE | Buy | Outperform |
| Sep 13, 2019 | Goldman Sachs | UPGRADE | Neutral | Buy |
| May 6, 2019 | China Renaissance | INITIATE | — | Buy |
| Jan 22, 2019 | CLSA | INITIATE | — | Buy |
| Sep 24, 2018 | Goldman Sachs | INITIATE | — | Neutral |
| Apr 23, 2018 | Morgan Stanley | INITIATE | — | Overweight |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Feb 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Jan 1, 2025 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Dec 1, 2024 | 0 | 0 | 3 | 4 | 1 | 0% | |
| Nov 1, 2024 | 0 | 0 | 3 | 4 | 1 | 0% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
No events recorded for this ticker. Events include FDA actions, clinical trials, enforcement actions, and market-moving developments.